BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sorgi CA, Soares EM, Rosada RS, Bitencourt CS, Zoccal KF, Pereira PAT, Fontanari C, Brandão I, Masson AP, Ramos SG, Silva CL, Frantz FG, Faccioli LH. Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB4 reduction but not PGE2 increment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020;1866:165574. [DOI: 10.1016/j.bbadis.2019.165574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Anh NK, Phat NK, Yen NTH, Jayanti RP, Thu VTA, Park YJ, Cho YS, Shin JG, Kim DH, Oh JY, Long NP. Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring. Biomed Pharmacother 2023;158:114187. [PMID: 36916440 DOI: 10.1016/j.biopha.2022.114187] [Reference Citation Analysis]
2 Groth M, Skrzydlewska E, Dobrzyńska M, Pancewicz S, Moniuszko-malinowska A. Redox Imbalance and Its Metabolic Consequences in Tick-Borne Diseases. Front Cell Infect Microbiol 2022;12:870398. [DOI: 10.3389/fcimb.2022.870398] [Reference Citation Analysis]
3 da Silva FL, de Campos Chaves Lamarque G, de Oliveira FMMPC, Nelson-Filho P, da Silva LAB, Segato RAB, Faccioli LH, Paula-Silva FWG. Leukotriene B4 loaded in microspheres regulate the expression of genes related to odontoblastic differentiation and biomineralization by dental pulp stem cells. BMC Oral Health 2022;22:45. [PMID: 35197043 DOI: 10.1186/s12903-022-02083-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Juárez E, Escalona-sarabia AL. Los eicosanoides como reguladores de procesos inflamatorios e inmunológicos en la tuberculosis pulmonar. NCT Neumología y Cirugía de Tórax 2022;81:109-120. [DOI: 10.35366/108497] [Reference Citation Analysis]
5 Llibre A, Dedicoat M, Burel JG, Demangel C, O'Shea MK, Mauro C. Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities. Front Immunol 2021;12:747387. [PMID: 34630426 DOI: 10.3389/fimmu.2021.747387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sheppe AEF, Santelices J, Czyz DM, Edelmann MJ. Yersinia pseudotuberculosis YopJ Limits Macrophage Response by Downregulating COX-2-Mediated Biosynthesis of PGE2 in a MAPK/ERK-Dependent Manner. Microbiol Spectr 2021;9:e0049621. [PMID: 34319170 DOI: 10.1128/Spectrum.00496-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sheppe AEF, Edelmann MJ. Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections. Infect Immun 2021;89:e0009521. [PMID: 34031130 DOI: 10.1128/IAI.00095-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Jøntvedt Jørgensen M, Nore KG, Aass HCD, Layre E, Nigou J, Mortensen R, Tasken K, Kvale D, Jenum S, Tonby K, Dyrhol-Riise AM. Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients. Front Cell Infect Microbiol 2021;11:669623. [PMID: 34307194 DOI: 10.3389/fcimb.2021.669623] [Reference Citation Analysis]
9 Pellegrini JM, Martin C, Morelli MP, Schander JA, Tateosian NL, Amiano NO, Rolandelli A, Palmero DJ, Levi A, Ciallella L, Colombo MI, García VE. PGE2 displays immunosuppressive effects during human active tuberculosis. Sci Rep 2021;11:13559. [PMID: 34193890 DOI: 10.1038/s41598-021-92667-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nienaber A, Hayford FEA, Variava E, Martinson N, Malan L. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis. Front Immunol 2021;12:623941. [PMID: 33777003 DOI: 10.3389/fimmu.2021.623941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kilinç G, Saris A, Ottenhoff THM, Haks MC. Host-directed therapy to combat mycobacterial infections. Immunol Rev 2021;301:62-83. [PMID: 33565103 DOI: 10.1111/imr.12951] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 14.5] [Reference Citation Analysis]
12 Fraga-Silva TFC, Maruyama SR, Sorgi CA, Russo EMS, Fernandes APM, de Barros Cardoso CR, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes. Front Immunol 2020;11:599736. [PMID: 33584667 DOI: 10.3389/fimmu.2020.599736] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
13 Malta-Santos H, Fukutani KF, Sorgi CA, Queiroz ATL, Nardini V, Silva J, Lago A, Carvalho LP, Machado PLR, Bozza PT, França-Costa J, Faccioli LH, Carvalho EM, Andrade BB, Borges VM. Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis. iScience 2020;23:101840. [PMID: 33313489 DOI: 10.1016/j.isci.2020.101840] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
14 Nore KG, Jørgensen MJ, Dyrhol-Riise AM, Jenum S, Tonby K. Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease. Front Immunol 2020;11:579849. [PMID: 33304347 DOI: 10.3389/fimmu.2020.579849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]